Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caron A Jacobson

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2019
Indolent lymphomas: pushing the pace with novel agentsCaron A Jacobson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2018
CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell LymphomaCaron A Jacobson
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in CAR T-cell therapy from the 61st American Society of Hematology Annual Meeting: commentaryCaron A Jacobson
Clinical Advances in Hematology & Oncology : H&O|August 7, 2024
Pilot data on axicabtagene ciloleucel for CNS lymphomaCaron A Jacobson
Hematology/Oncology Clinics of North America|June 24, 2019
Redefining Non-Hodgkin Lymphoma: Using Genomic Subtypes to Improve Treatment OptionsCaron A Jacobson
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentaryCaron A Jacobson
Leukemia & Lymphoma|February 3, 2025
T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategiesKatie Maurer, Caron A Jacobson
Blood Advances|July 14, 2023
Comorbidities in DLBCL: too "Severe4" CAR-T therapy?David Qualls, Caron A Jacobson
Best Practice & Research. Clinical Haematology|September 15, 2018
Immunotherapy in aggressive B-cell lymphomasCaron A Jacobson, Philippe Armand
Haematologica|November 2, 2010
B-cell-directed therapy for chronic graft-versus-host diseaseCaron A Jacobson, Jerome Ritz
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Hematology. American Society of Hematology. Education Program|December 7, 2019
Indolent lymphomas: pushing the pace with novel agentsCaron A Jacobson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2018
CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell LymphomaCaron A Jacobson
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in CAR T-cell therapy from the 61st American Society of Hematology Annual Meeting: commentaryCaron A Jacobson
Clinical Advances in Hematology & Oncology : H&O|August 7, 2024
Pilot data on axicabtagene ciloleucel for CNS lymphomaCaron A Jacobson
Hematology/Oncology Clinics of North America|June 24, 2019
Redefining Non-Hodgkin Lymphoma: Using Genomic Subtypes to Improve Treatment OptionsCaron A Jacobson
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentaryCaron A Jacobson
Leukemia & Lymphoma|February 3, 2025
T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategiesKatie Maurer, Caron A Jacobson
Blood Advances|July 14, 2023
Comorbidities in DLBCL: too "Severe4" CAR-T therapy?David Qualls, Caron A Jacobson
Best Practice & Research. Clinical Haematology|September 15, 2018
Immunotherapy in aggressive B-cell lymphomasCaron A Jacobson, Philippe Armand
Haematologica|November 2, 2010
B-cell-directed therapy for chronic graft-versus-host diseaseCaron A Jacobson, Jerome Ritz
Pageof 14